VivoSim Labs (VIVS) Amortization of Deferred Charges (2012 - 2026)
VivoSim Labs (VIVS) posted quarterly Amortization of Deferred Charges of $118000.0 for Q1 2026, up 6.31% year-over-year from $111000.0 in Q1 2025, and up 1.72% quarter-over-quarter from $116000.0 in Q4 2025.
VivoSim Labs (VIVS) Amortization of Deferred Charges (2012 - 2026) Analysis & Trends
VivoSim Labs' Amortization of Deferred Charges history runs 4 years deep, the most recent figure standing at $118000.0 for Q1 2026.
- In Q1 2026, Amortization of Deferred Charges rose 6.31% year-over-year to $118000.0; the TTM figure through Mar 2026 stood at $460000.0 (up 6.48% YoY), while the FY2026 annual figure was $460000.0, up 6.48% from the prior year.
- Amortization of Deferred Charges for Q1 2026 stood at $118000.0, up from $116000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $118000.0 in Q1 2026, with the low at $105000.0 in Q2 2024.
- The 3-year median for Amortization of Deferred Charges is $111500.0 (2025), against an average of $111500.0.
- The sharpest annual moves came in 2025 and 2026: Amortization of Deferred Charges advanced 6.67% in 2025, then climbed 6.31% in 2026.
- VivoSim Labs' Amortization of Deferred Charges stood at $109000.0 in 2024, then rose by 6.42% to $116000.0 in 2025, then grew by 1.72% to $118000.0 in 2026.
- Business Quant data shows VIVS's Amortization of Deferred Charges at $118000.0 in Q1 2026, $116000.0 in Q4 2025, and $114000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | VivoSim Labs | 1.49 Mn | 1.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 120,000.00 |
| Jun 30, 2026 | 120,000.00 |
| Mar 31, 2026 | 118,000.00 |
| Mar 31, 2026 | 118,000.00 |
| Dec 31, 2025 | 116,000.00 |
| Dec 31, 2025 | 116,000.00 |
| Sep 30, 2025 | 114,000.00 |
| Sep 30, 2025 | 114,000.00 |
| Jun 30, 2025 | 112,000.00 |
| Jun 30, 2025 | 112,000.00 |
| Mar 31, 2025 | 111,000.00 |
| Mar 31, 2025 | 111,000.00 |
| Dec 31, 2024 | 109,000.00 |
| Dec 31, 2024 | 109,000.00 |
| Sep 30, 2024 | 107,000.00 |
| Sep 30, 2024 | 107,000.00 |
| Jun 30, 2024 | 105,000.00 |
| Jun 30, 2024 | 105,000.00 |
| Dec 31, 2012 | 157.00 |
| Dec 31, 2012 | 157.00 |